title: PIK3CA mutations in HER2-positive breast cancer: an ongoing conundrum.
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
authors.forename: S
authors.initials: S
authors.lastname: Goel
authors.affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA ian_krop@dfci.harvard.edu.
authors.forename: I E
authors.initials: IE
authors.lastname: Krop
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D006801:Humans; D009154:Mutation; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
chemical_list: D019869:Phosphatidylinositol 3-Kinases; D018719:Erb-b2 Receptor Tyrosine Kinases